by University of Liverpool Credit: CC0 Public Domain A new systematic review by University of Liverpool researchers highlights the positive impact that triple-combination therapy has on the wellbeing of people with Cystic Fibrosis (CF). In August 2020, the European Commission formally granted a license to Kaftrio, the first triple-combination therapy to tackle the underlying cause of...
